2002

Gilead made misleading and illegal statements about Viread, says FDA

11 May 2002. Related: Other news.

Barcelona conference organisers issue nine-point plan of action on global emergency

11 May 2002. Related: Other news.

Incorporating antiretroviral resistance testing into clinical practice

11 May 2002. Related: On the web.

Management of co-infection with HIV and TB

11 May 2002. Related: On the web.

Volume 3 Number 4 May 2002 PDF

1 May 2002. Related: PDFs.

South Africa finds 1 billion Rand to treble HIV budget, after Mandela confronts Mbeki

10 April 2002. Related: Treatment access.

9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002

10 April 2002. Related: Conference reports.

Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars

10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.

Switch to abacavir improves lipoatrophy

10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.

Potential use of niacin to reduce intra-abdominal fat

10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.

Further benefits shown with New-Fill for facial atrophy

10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.

Lipodystrophy associated with lower CD4+ T cell counts

10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.

Treatment interruptions

10 April 2002. Related: Conference reports.

Analysis of cells from long term non-progressors points the way to using vaccines and STIs to restore immune response to HIV

10 April 2002. Related: Conference reports.

Symposium on T cell turnover and thymic function

10 April 2002. Related: Conference reports.

New drugs: perhaps some genuine excitement this time

10 April 2002. Related: Conference reports, Antiretrovirals.

T20 and beyond: inhibition of HIV attachment and fusion at the 9th CROI

10 April 2002. Related: Conference reports, Antiretrovirals.

Pharmacogenetics predict abacavir hypersensitivity

10 April 2002. Related: Conference reports, Antiretrovirals.

Pregnancy: growing body of evidence supports treating maternal disease

10 April 2002. Related: Conference reports, Pregnancy.

Peripheral neuropathy update

10 April 2002. Related: Conference reports, Side effects.

Further Retroconference reports and data on the web

10 April 2002. Related: On the web.

Passive transfer of scrub typhus plasma linked to reduced HIV viral load and clinical improvement

10 April 2002. Related: Basic science and immunology.

Rivals Robert Gallo and Luc Montagnier launch joint vaccine project

10 April 2002. Related: Other news.

Abbott announces therapeutic drug monitoring scheme for lopinavir/r

10 April 2002. Related: Other news.

Johnson and Johnson to acquire Tibotec-Virco

10 April 2002. Related: Other news.

Increased selenium intake may protect HIV positive patients from mycobacterial disease

10 April 2002. Related: Coinfections and complications.

HIV protease inhibitors have potent antiangiogenesis, antitumor effects

10 April 2002. Related: Basic science and immunology.

PRO 542: reduced viral loads in patients failing conventional therapy

10 April 2002. Related: Other news.

Researchers uncover possible drug approach to attack HIV-infected cells

10 April 2002. Related: Other news.

Leptin reverses lipodystrophy in diabetic patients

10 April 2002. Related: Side effects, Lipodystrophy and metabolic complications.

Entry criteria changed for Optima study and treatment options for salvage therapy

10 April 2002. Related: Other news.

IL-2 still available in UK in ESPRIT study, safety management guidelines expanded

10 April 2002. Related: Other news.

Controlling PI resistance like a switch: MDR1 and p-glycoprotein

10 April 2002. Related: On the web.

How do proteins cause drug resistance?

10 April 2002. Related: On the web.

HE2000

10 April 2002. Related: On the web.

Volume 3 Number 3 April 2002 PDF

1 April 2002. Related: PDFs.

Meeting calls for NHS funding and training to provide repair treatment for people with facial lipoatrophy

10 March 2002. Related: Special reports, Treatment access, Side effects, Lipodystrophy and metabolic complications.

South African treatment activists defy patent laws to import generic antiretrovirals from Brazil

10 March 2002. Related: Treatment access.

Hepatic injury with nevirapine related to drug level and hepatitis C infection

10 March 2002. Related: Antiretrovirals, Side effects.

Study finds that PI-containing regimens have a beneficial effect on oral candidiasis independent of any immune reconstitution

10 March 2002. Related: Antiretrovirals, Coinfections and complications.

Tenofovir DF approved for marketing in European Union

10 March 2002. Related: Antiretrovirals.

It may be important to screen and treat riboflavin deficiency in patients on nucleoside analogues

10 March 2002. Related: Antiretrovirals, Side effects.

Managing the metabolic side effects of antiretroviral therapy

10 March 2002. Related: Side effects, Lipodystrophy and metabolic complications.

Intensive diet and exercise regimen may help fight lipodystrophy

10 March 2002. Related: Side effects, Lipodystrophy and metabolic complications.

Avascular necrosis (AVN) may be increasingly common in HIV-positive patients

10 March 2002. Related: Side effects.

Rheumatological complications associated with the use of indinavir and other protease inhibitors

10 March 2002. Related: Side effects.

Reseeding of viral reservoirs may explain poor response to HAART interruption

10 March 2002. Related: Basic science and immunology.

Smoking damages quality of life for people with HIV, says study

10 March 2002. Related: Other news.

Nutritional supplements can help people gain weight, raise CD4 counts

10 March 2002. Related: Other news.